# Exhibit Review — Gemini 3 Flash (Round 1)

**Role:** Visual exhibit advisor
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-03-03T05:21:35.822241
**Route:** Direct Google API + PDF
**Tokens:** 26717 in / 2072 out
**Response SHA256:** 9cb6313eb67e8183

---

# Exhibit-by-Exhibit Review

## Main Text Exhibits

### Figure 1: "Staggered adoption of must-access PDMP mandates, 2012–2019"
**Page:** 12
- **Formatting:** Clean and professional. Use of dual axes is appropriate here to show both flow and stock.
- **Clarity:** Excellent. The combination of bars (annual) and line (cumulative) clearly shows the "bulk" of adoption in the mid-2010s.
- **Storytelling:** This is a vital "first figure" for any staggered DiD paper. It justifies the use of the Callaway-Sant’Anna estimator by showing the variation in treatment timing.
- **Labeling:** Clear. Legend for the red line is integrated into the plot area, which reduces eye movement.
- **Recommendation:** **KEEP AS-IS**

### Table 1: "Summary Statistics: Treated vs. Never-Treated States"
**Page:** 15
- **Formatting:** Standard "Table 1" format. Numbers are reasonably aligned, though "SD" columns could be more strictly decimal-aligned.
- **Clarity:** Logical grouping. The dashes for standard deviations on counts (Prescriber share) are a bit distracting; usually, the SD is provided or the column is left blank without dashes.
- **Storytelling:** Essential. It immediately flags the level differences (6.03% vs 5.15%) that motivate the DiD approach over a simple cross-sectional comparison.
- **Labeling:** "Notes" are comprehensive. The definition of "Opioid prescribing rate" is helpful.
- **Recommendation:** **REVISE**
  - Remove the em-dashes (—) in the SD columns for the bottom three rows. If the SD is not calculated for those means, leave the cell empty for a cleaner look.
  - Decimal-align all numeric columns.

### Table 2: "Effect of Must-Access PDMP Mandates on Opioid Prescribing"
**Page:** 19
- **Formatting:** Professional "AER-style" table. 
- **Clarity:** High. Comparing CS-DiD and TWFE side-by-side for each outcome allows the reader to quickly see that the "modern" corrections don't change the story much.
- **Storytelling:** This is the core empirical result. It effectively communicates that the main effect is a null/modest reduction.
- **Labeling:** Significance stars are defined. Standard errors are in parentheses. 
- **Recommendation:** **KEEP AS-IS**

### Figure 2: "Effect of Must-Access PDMP on Opioid Prescribing Rate"
**Page:** 20
- **Formatting:** Good use of the "fanchart" style for confidence intervals. 
- **Clarity:** The "Pre-treatment" and "Post-treatment" labels are very helpful for 10-second parsing. The light blue shading is distinct.
- **Storytelling:** The flat pre-trend is the "money shot" for the identification strategy.
- **Labeling:** Y-axis clearly states "pp" (percentage points). 
- **Recommendation:** **KEEP AS-IS** (Consider increasing the font size of the axis tick labels slightly for better readability in a printed journal).

### Figure 3: "Effect of Must-Access PDMP on Opioid Prescriber Share"
**Page:** 21
- **Formatting:** Consistent with Figure 2, but in green.
- **Clarity:** The wide confidence intervals in the post-period clearly show the null result.
- **Storytelling:** Supports the "intensive margin" argument (doctors didn't quit, they just prescribed less per patient).
- **Labeling:** Good.
- **Recommendation:** **REVISE**
  - This figure is secondary to Figure 2. To save space in the main text of a top journal, consider making this **Panel B** of a single "Figure 2: Event Study Estimates," where the prescribing rate is Panel A.

### Figure 4: "Opioid Prescribing Rate by PDMP Adoption Status"
**Page:** 22
- **Formatting:** Clean. Good use of shading for uncertainty.
- **Clarity:** Very high. 
- **Storytelling:** This is a crucial "transparency" figure. It shows that while the DiD might find a small effect, the national secular trend is the dominant force. This adds significant credibility.
- **Labeling:** Axis labels and legend are clear.
- **Recommendation:** **KEEP AS-IS**

### Table 3: "Welfare Calibration: Net Welfare per Prevented Prescription by Behavioral Model"
**Page:** 25
- **Formatting:** Clean, logical layout.
- **Clarity:** The "Sign" column is a great addition for a quick takeaway.
- **Storytelling:** This is the most important table in the paper. It bridges the theory and the empirics.
- **Labeling:** The note explains the $0.72 threshold calculation clearly.
- **Recommendation:** **KEEP AS-IS**

### Figure 5: "Welfare Effect of PDMP per Prescription Reduced"
**Page:** 26
- **Formatting:** Highly professional. The "Literature consensus range" shading is an excellent touch.
- **Clarity:** The annotations (Cue-Triggered, Rational Addiction) make the graph self-explanatory.
- **Storytelling:** Visually summarizes the paper's core theoretical/calibration contribution.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

### Figure 6: "Leave-One-Out Sensitivity"
**Page:** 30
- **Formatting:** Standard coefficient plot.
- **Clarity:** Shows the stability of the result across state exclusions.
- **Storytelling:** Good for robustness, but perhaps not "main text" essential for a top journal that prioritizes space.
- **Labeling:** Clear.
- **Recommendation:** **MOVE TO APPENDIX**

---

## Appendix Exhibits

### Table 4: "Robustness: Alternative Estimators and Specifications"
**Page:** 28
- **Formatting:** Professional.
- **Clarity:** Logical grouping of "Estimators" and "Placebo outcomes."
- **Storytelling:** This table is quite strong. The placebo outcomes (total prescribers, total claims) are very convincing.
- **Recommendation:** **PROMOTE TO MAIN TEXT**
  - Top journals like Econometrica or AER value seeing these "specification checks" and "placebos" early. Merging this with Table 2 (as additional rows or a second panel) would consolidate the empirical "cleanliness" of the paper in one place.

### Table 5: "Sensitivity of Critical Threshold β* to Calibration Parameters"
**Page:** 47
- **Formatting:** Heatmap-style table (though without colors).
- **Clarity:** Clearly shows how the threshold moves with the two most uncertain parameters.
- **Storytelling:** Vital for addressing the "calibrated parameters" limitation.
- **Recommendation:** **KEEP AS-IS** (in Appendix)

### Table 6: "Must-Access PDMP Mandate Adoption by State"
**Page:** 48
- **Formatting:** Simple list.
- **Clarity:** High.
- **Storytelling:** Reference material.
- **Recommendation:** **KEEP AS-IS**

### Table 7: "Full Event-Study Coefficients: Opioid Prescribing Rate"
**Page:** 49
- **Formatting:** Standard.
- **Clarity:** Re-states the Figure 2 data in table form.
- **Storytelling:** Redundant with Figure 2 but necessary for the appendix.
- **Recommendation:** **KEEP AS-IS**

---

## Overall Assessment

- **Exhibit count:** 5 main tables (if Table 4 promoted), 4 main figures (if Fig 3/6 moved), 3 appendix tables, 1 appendix figure.
- **General quality:** Extremely high. The paper follows the "Chetty style" of welfare analysis—clean figures, transparent identification, and a focus on "sufficient statistics."
- **Strongest exhibits:** Figure 5 (Welfare threshold), Table 3 (Welfare Calibration), Figure 4 (Raw Trends).
- **Weakest exhibits:** Figure 6 (Leave-one-out) - it's standard but visually simple; Table 1 (SD dashes).
- **Missing exhibits:** 
    - **A Theoretical Map/Schematic:** A small flow chart showing the "gatekeeper" model (Physician -> Patient -> Costs) could help readers visualize the agency wedge $\phi$.
    - **Map of Treatment:** A US map shaded by adoption year is often expected in these papers to check for geographic clustering of treatment.

- **Top 3 improvements:**
  1. **Consolidate Event Studies:** Merge Figure 2 and Figure 3 into a single multi-panel figure (Panel A: Prescribing Rate, Panel B: Prescriber Share). This is standard for QJE/AER.
  2. **Strategic Promotion:** Move the "Placebo Outcomes" and "Alternative Estimators" (currently Table 4) into the main text, possibly merging them into Table 2. This reinforces the "clean identification" narrative before the reader reaches the welfare section.
  3. **Streamline Main Text:** Move Figure 6 (Leave-one-out) to the Appendix. While useful, the stability of the result is already well-demonstrated by the comparison of estimators in Table 2/4.